Clinical Trials Directory

Trials / Completed

CompletedNCT04020939

The Role of Indocyanine Green Angiography Fluorescence on Intestinal Resections in Pediatric Surgery.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
35 (actual)
Sponsor
St. Justine's Hospital · Academic / Other
Sex
All
Age
0 Years – 16 Years
Healthy volunteers
Accepted

Summary

Background: Intestinal resections are commonly performed in the pediatric population. Perfusion of the bowel is one of the most important factors determining the viability of an intestinal anastomosis. Up to date, no ideal method to assess intestinal perfusion has proven its superiority. Objectives: Primary: The aim of this study is to establish the feasibility and impact of the use of indocyanine green technology on intestinal resection margins during elective and emergency pediatric surgeries. Secondary: The secondary outcomes of interest include collection of adverse events and difficulties encountered with the use of the indocyanine green (ICG) technology. Postoperative surgical complications will also be recorded. Study Design: An open observational clinical study will be performed by using a clinical drug (indocyanine green) and medical device (SPY Fluorescence Imaging) to assess intraoperatively intestinal perfusion in a specific pediatric population.

Conditions

Interventions

TypeNameDescription
DEVICESPY imagingUse of the SPY Pinpoint imaging device to evaluate intraoperative intestinal perfusion in children.
DRUGIndocyanine GreenIntravenous injection of indocyanine green to evaluate the intestinal perfusion.

Timeline

Start date
2020-03-16
Primary completion
2021-03-10
Completion
2021-03-10
First posted
2019-07-16
Last updated
2021-03-17

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT04020939. Inclusion in this directory is not an endorsement.